Green Cross Medical Science's latest marketcap:
As of 07/31/2025, Green Cross Medical Science's market capitalization has reached $63.23 M. According to our data, Green Cross Medical Science is the 28167th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 63.23 M |
| Revenue (ttm) | 76.42 M |
| Net Income (ttm) | 1.18 M |
| Shares Out | 21.71 M |
| EPS (ttm) | 0.01 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 12/29/2014 |
| Earnings Date | 08/14/2025 |
Green Cross Medical Science's yearly market capitalization.
| Date | Market Cap(₩) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 07/31/2025 | ₩88.24 B | $63.23 M | 11.59% | 28167 |
| 12/30/2024 | ₩77.71 B | $52.07 M | -22.72% | 27731 |
| 12/28/2023 | ₩100.56 B | $77.43 M | -17.47% | 24789 |
| 12/29/2022 | ₩121.86 B | $96.27 M | -20% | 22538 |
| 12/30/2021 | ₩152.32 B | $127.95 M | -53.95% | 21526 |
| 12/30/2020 | ₩330.76 B | $304.3 M | 199.05% | 14466 |
| 12/30/2019 | ₩110.6 B | $95.12 M | -6.7% | 18406 |
| 12/28/2018 | ₩118.54 B | $105.5 M | 4.64% | 17015 |
| 12/28/2017 | ₩113.29 B | $105.36 M | 8.22% | 17707 |
| 12/29/2016 | ₩104.68 B | $85.84 M | -23.43% | 16624 |
Company Profile
About Green Cross Medical Science Corporation
Green Cross Medical Science Corporation is a leading manufacturer and supplier of diagnostic reagents and medical devices, serving both South Korea and international markets.
Product Offerings
- Immunology Diagnostic Reagents – High-quality reagents for accurate immunological testing.
- COVID-19 Testing Kits – Reliable diagnostic solutions for COVID-19 detection.
- Blood Glucose Monitoring System – Advanced tools for diabetes management.
- HbA1c Test Machine – Precise hemoglobin A1c testing for long-term glucose monitoring.
- Gcare LIPID & LIPID Printer – Comprehensive lipid testing and printing solutions.
Company Background
Founded in 1972, Green Cross Medical Science Corporation is headquartered in Yongin-Si, South Korea, with decades of expertise in medical diagnostics and healthcare innovation.
Frequently Asked Questions
-
What is Green Cross Medical Science's (KOSDAQ-142280) current market cap?As of 07/31/2025, Green Cross Medical Science (including the parent company, if applicable) has an estimated market capitalization of $63.23 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Green Cross Medical Science (KOSDAQ-142280) rank globally by market cap?Green Cross Medical Science global market capitalization ranking is approximately 28167 as of 07/31/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.